T. Rowe Price Associates’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,219
Closed -$137K 2731
2020
Q3
$137K Hold
2,219
﹤0.01% 2484
2020
Q2
$196K Sell
2,219
-24
-1% -$2.12K ﹤0.01% 2356
2020
Q1
$251K Buy
2,243
+393
+21% +$44K ﹤0.01% 2247
2019
Q4
$453K Buy
1,850
+1,674
+951% +$410K ﹤0.01% 2177
2019
Q3
$61K Buy
176
+2
+1% +$693 ﹤0.01% 2471
2019
Q2
$161K Buy
174
+1
+0.6% +$925 ﹤0.01% 2424
2019
Q1
$276K Buy
173
+1
+0.6% +$1.6K ﹤0.01% 2316
2018
Q4
$322K Sell
172
-2,584
-94% -$4.84M ﹤0.01% 2244
2018
Q3
$6.5M Buy
2,756
+27
+1% +$63.7K ﹤0.01% 1433
2018
Q2
$9.4M Buy
2,729
+704
+35% +$2.42M ﹤0.01% 1353
2018
Q1
$5.75M Buy
2,025
+544
+37% +$1.54M ﹤0.01% 1410
2017
Q4
$3.81M Sell
1,481
-313
-17% -$805K ﹤0.01% 1443
2017
Q3
$5.09M Buy
1,794
+283
+19% +$803K ﹤0.01% 1420
2017
Q2
$3.57M Sell
1,511
-3,406
-69% -$8.05M ﹤0.01% 1458
2017
Q1
$12.4M Sell
4,917
-53
-1% -$134K ﹤0.01% 1288
2016
Q4
$11.2M Sell
4,970
-1,024
-17% -$2.31M ﹤0.01% 1291
2016
Q3
$15M Buy
5,994
+4,559
+318% +$11.4M ﹤0.01% 1220
2016
Q2
$4.39M Sell
1,435
-4
-0.3% -$12.2K ﹤0.01% 1410
2016
Q1
$4.57M Buy
1,439
+44
+3% +$140K ﹤0.01% 1413
2015
Q4
$7.16M Buy
1,395
+327
+31% +$1.68M ﹤0.01% 1355
2015
Q3
$3.4M Sell
1,068
-1,621
-60% -$5.15M ﹤0.01% 1486
2015
Q2
$10.8M Sell
2,689
-33
-1% -$132K ﹤0.01% 1327
2015
Q1
$10.9M Buy
2,722
+134
+5% +$535K ﹤0.01% 1318
2014
Q4
$12.7M Buy
2,588
+16
+0.6% +$78.5K ﹤0.01% 1257
2014
Q3
$10.5M Buy
2,572
+3
+0.1% +$12.2K ﹤0.01% 1297
2014
Q2
$10.4M Sell
2,569
-5
-0.2% -$20.2K ﹤0.01% 1306
2014
Q1
$11.7M Sell
2,574
-14
-0.5% -$63.7K ﹤0.01% 1263
2013
Q4
$9.07M Sell
2,588
-116
-4% -$406K ﹤0.01% 1311
2013
Q3
$11.1M Buy
2,704
+7
+0.3% +$28.8K ﹤0.01% 1240
2013
Q2
$10.7M Buy
+2,697
New +$10.7M ﹤0.01% 1227